[EN] MORPHOLINONE COMPOUNDS AS FACTOR IXA INHIBITORS<br/>[FR] COMPOSÉS DE MORPHOLINONE EN TANT QU'INHIBITEURS DE FACTEUR IXA
申请人:MOCHIDA PHARM CO LTD
公开号:WO2010065717A1
公开(公告)日:2010-06-10
The present invention provides a compound of Formula (I) as described herein, or a pharmaceutically acceptable salt or a solvate thereof. The present invention also provides pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing a thromboses, embolisms, hypercoagulability or fibrotic changes.
本发明提供了如下描述的化合物I的化合物,或其药用可接受的盐或溶剂。本发明还提供包含一个或多个所述化合物的药物组合物,以及使用所述化合物治疗或预防血栓、栓塞、高凝血性或纤维变化的方法。